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Background: Our purpose was to examine the value of the first postoperative day review after uneventful
phacoemulsification cataract surgery.
Methods: 291 patients who underwent uneventful phacoemulsification were randomized into two groups
(ClinicalTrials.gov Identifier: NCT01247155): i) Next day review (NDR group, n = 146) and ii) No next day review
(NNDR group, n = 145). The rate of complications, percentage of patients seeking non-scheduled medical
consultation up to postoperative day 14, presence of any inflammation-related sign and best corrected visual acuity
(BCVA) on postoperative day 28 were analyzed.
Results: In the NDR group, 5.5% of patients developed a postoperative complication, whereas the respective rate
was 6.2% in the NNDR group. The difference was not statistically significant (p = 0.791). The most frequent
complications were: elevated intraocular pressure, allergy to postoperative treatment, corneal abrasion, punctuate
epitheliopathy, iris prolapse and postoperative hyphema, whose rates did not differ between the two groups. The
rate of patients seeking non-scheduled medical consultation up to postoperative day 14, presence of any
inflammation-related sign, as well as BCVA on day 28 did not exhibit any significant differences between the study
groups.
Conclusions: First postoperative day review could be omitted in cases of uneventful cataract surgery.
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Cataract surgery is one of the most common surgical
procedures worldwide [1,2]. Phacoemulsification and
recent advances in cataract surgery techniques lead to
improved postoperative outcomes, as well as to
reduced intra- and postoperative complications [2,3].
Therefore, there is a tendency in discharging patients
on the same day of surgery, without first day post-
operative review [3-6], which is considered to be an
increasing issue due to economic reasons. Neverthe-
less, routine review on the first day postoperatively has
several advantages, such as the early detection of* Correspondence: eirchat@yahoo.gr
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reproduction in any medium, provided the orcomplications, reassurance for the patient and training
of staff [3]. As a result, there have been studies which
stated that first day postoperative review after unevent-
ful phacoemulcification cataract surgery is necessary
and others that could not make specific recommenda-
tions for the necessity of it [7-9].
Under the light of the above, the purpose of this ran-
domized trial was to examine the value of the review on
the first-postoperative day after uneventful phacoemulsi-
fication cataract surgery. Three outcomes were adopted
in this study, so as to yield a global, comprehensive ap-
proach: i. percentage of patients seeking non-scheduled
medical consultation up to postoperative day 14, ii. pres-
ence of any inflammation-related signs (corneal edema,
Tyndall effect, conjunctival hyperemia) [10] on post-
operative day 28 and iii. best corrected visual acuity
(BCVA) on postoperative day 28.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Chatziralli et al. BMC Research Notes 2012, 5:333 Page 2 of 5
http://www.biomedcentral.com/1756-0500/5/333Methods
The patients were recruited from the Department of
Ophthalmology, General Hospital of Veroia, Veroia,
Greece over a 10-month period. Patients were randomly
selected from the grand pool of phacoemulsification pro-
cedures taking place in the Department; the random se-
lection was based on random numbers allocation, so as
to eliminate any selection bias. 311 patients were asked
to participate and 304 consented (participation rate:
97.7%). Patients’ recorded data included age, sex, current
smoking habits and clinical features, such as presence of
hypertension, diabetes mellitus (with or without diabetic
retinopathy), pseudoexfoliation, glaucoma and age-
related macular degeneration. All patients underwent a
full ophthalmologic examination preoperatively i.e.,
measurement of BCVA (Snellen chart), slit lamp exam-
ination, tonometry and fundoscopy in addition to a
complete medical history. The study was in accordance
with the Declaration of Helsinki and has been approved
by the Institutional Review Board of General Hospital of
Veroia, Veroia, Greece. Written informed consent was
obtained from all patients.
All patients underwent routine phacoemulsification
cataract surgery with posterior chamber intraocular lens
implantation by the same consultant surgeon (LP) and
were randomized to one of the two postoperative follow-
up groups: i) Next day review (NDR group, n = 146) and
ii) No next day review (NNDR group, n = 145). Patients
assigned to the NDR group stayed at the hospital for theFigure 1 Flow chart depicting the exclusion criteria and randomizatio
posterior capsule rupture; IOC: intra-operative complications.first postoperative night, while a doctor examined them
in the following morning (slit lamp examination, tono-
metry). On the other hand, patients allocated to the
NNDR group were discharged 3–4 hours after surgery.
Exclusion criteria were the following: i) intra-operative
complications, such as posterior capsule rupture, vitre-
ous loss, lost nucleus, zonule dehiscence and wound
leak, ii) inadequate social support for overnight care at
home, iii) severely limited visual potential in the fellow
eye, iv) uveitis or ocular trauma, v) severe systemic dis-
eases limiting activity, vi) patients with learning disability
or dementia.
All patients received the same postoperative treatment
i.e., combination of tobramycin 0.3% - dexamethasone
0.1% (TobraDexW, Alcon), one drop four times/day, plus
ketorolac tromethamine 0.5% (AcularW, Allergan), one
drop three times/day. The topical treatment was admi-
nistered for 28 days after phacoemulsification. Appropri-
ate postoperative instructions were given to all patients
in addition to a contact telephone number for emergen-
cies. Two follow-up visits were scheduled for all patients:
one on postoperative day 14 and one on postoperative
day 28. On postoperative day 14 slit lamp examination,
tonometry and fundoscopy were performed; special at-
tention was paid to record whether the patient had
sought non-scheduled medical consultation up to post-
operative day 14. On postoperative day 28 slit lamp
examination, tonometry, fundoscopy and BCVA meas-
urement were conducted. All patients were evaluated byn of patients. NDR: next day review; NNDR: non next day review; PCR:
Table 2 The profile of complications in the two study
groups
Complications NDR group NNDR group p*
N(%) N(%)
Postoperative complications
Allergy to postoperative treatment 3 (2.1) 1 (0.7) 0.622
Iris prolapse 0 (0.0) 1 (0.7) 0.498
Corneal abrasion 2 (1.4) 2 (1.4) >0.999
Elevated intraocular pressure
(>30 mmHg)
2 (1.4) 4 (2.8) 0.447
Punctuate epitheliopathy 2 (1.4) 1 (0.7) >0.999
Postoperative hyphema 0 (0.0) 1 (0.7) 0.498
*p-values derived from Fisher’s exact test.
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tion procedures and specifically by two independent
examiners.
Three outcomes were adopted in this study: i. percent-
age of patients seeking non-scheduled medical consult-
ation up to postoperative day 14, ii. presence of any
inflammation-related signs (corneal edema, Tyndall ef-
fect, conjunctival hyperemia) on postoperative day 28
and iii. BCVA on postoperative day 28.
The differences in baseline characteristics, incidence of
postoperative complications between the two groups, as
well as between outcomes were compared by Chi-square
test or Fisher’s exact test (concerning categorical vari-
ables) or Mann–Whitney-Wilcoxon (MWW) test for in-
dependent samples (concerning continuous variables), as
appropriate. Concerning BCVA, the descriptive statistics
of the log of the minimum angle of resolution (logMAR)
were computed as appropriate [11]. Statistical analysis
was performed with STATA 8.0 statistical software
(StataCorp, College Station, TX, USA).Results
The study design, as well as the randomization of
patients in the two groups, is depicted in the respective
flow chart (Figure 1). Table 1 represents the baseline
demographic, clinical features and lifestyle habits of the
study groups. The postoperative complications with their
statistical significance are illustrated in Table 2. Of the
146 patients randomized to NDR group, eight (5.5%;
95%CI: 2.4%-10.5%) developed a postoperative complica-
tion vs. nine (6.2%; 95%CI: 2.9%-11.5%) of 145 patients
in the NNDR group. The difference was not statisticallyTable 1 The baseline features of the two study groups





mean± SD mean± SD
Age (years) 75.4 ± 7.2 75.8 ± 7.0 0.584MWW
BCVA prior to
phacoemulsification (logMAR)
0.59 ± 0.13 0.63 ± 0.14 0.193MWW
Categorical and ordinal
variables
N (%) N (%)
Sex (male) 73 (50.0) 79 (54.5) 0.444C
Current smoking (yes) 24 (16.4) 20 (13.8) 0.529C
Hypertension (yes) 104 (71.2) 113 (77.9) 0.190C
Diabetes mellitus (yes) 24 (16.4) 23 (15.9) 0.894C
Diabetic retinopathy (yes) 14 (9.6) 11 (7.5) 0.530C
Glaucoma (yes) 13 (8.9) 17 (11.7) 0.429C
Pseudoexfoliation (yes) 44 (30.1) 35 (24.1) 0.250C
Age-related macular
degeneration (yes)
11 (7.5) 10 (6.9) 0.834C
MWWp-value derived from Mann–Whitney-Wilcoxon test for independent
samples, Cp-value derived from Pearson’s chi-square, Fp-value derived from
Fisher’s exact test.significant (p = 0.791, Chi-square test). Two patients
(one in the NDR group and one in the NNDR group)
presented with coexistent corneal abrasion and punctu-
ate epitheliopathy; as a result, the total number of com-
plications in the NDR and NNDR group were nine and
ten, respectively.
Worthy of note, regarding NDR group, all complica-
tions appearing in Table 2 became evident on next-day
review, except for allergy to postoperative treatment
which prompted patients to seek non-scheduled medical
consultation (see below). With respect to NNDR group,
all complications had become evident prior to post-
operative day 14, either at the scheduled visit or at a
non-scheduled consultation (two patients, see below).
Concerning the three outcomes of the study, no statis-
tically significant differences were noted (Table 3). The
percentage of patients seeking non-scheduled medical
consultation up to postoperative day 14 was minimal in
both groups; accordingly, the frequency of any
inflammation-related sign was scarce on postoperative
day 28. It is worth mentioning that the underlying cause
in all three patients seeking non-scheduled medical con-
sultation up to postoperative day 14 in NDR group was
allergy to postoperative treatment (allergy emerged on
postoperative day 2 for two patients and on postoperative
day 3 for one patient); on the contrary, the underlying
cause for the respective two cases in NNDR group was
corneal abrasion (the two patients sought non-scheduled
medical consultation due to pain on postoperative day 5
and 9, respectively). BCVA on postoperative day 28 did
not exhibit statistically significant difference between the
two groups (0.06 ± 0.08 vs. 0.06 ± 0.06 for NDR and
NNDR respectively, p = 0.859, MWW). Of note, the
agreement between the two examiners was 100%, regard-
ing the assessment at day 14 and day 28.
Discussion
The principal message of this study is that the first post-
operative day review could be omitted after uneventful
Table 3 Frequency of the study outcomes in the two
study groups






3 (2.1) 2 (1.4) >0.999F
Presence of any
inflammation-related sign
on postoperative day 28
2 (1.4) 2 (1.4) >0.999F
Continuous outcome mean± SD
BCVA on postoperative day 28 8.77 ± 1.27 8.85 ± 1.13 0.859MWW
Fp-value derived from Fisher’s exact test, MWWp-value derived from
Mann–Whitney-Wilcoxon test for independent samples.
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serious complications detected on the first postoperative
day was low and there was no statistically significant dif-
ference between the two groups concerning non-
scheduled consultation, inflammation-related signs or
postoperative complications. Moreover, BCVA seems
not to be affected by the first day postoperative review,
as Tinley et al. have also noted [4].
Regarding complications, iris prolapse is rare after
small incision cataract surgery and is thought to be asso-
ciated with poor wound construction or postoperative
manipulation [8]. Allergy to postoperative treatment is
not a vision-threatening complication and can be pre-
dicted based on a thorough medical history [12]. With
respect to corneal abrasion, pain was the symptom that
led patients to seek non-scheduled advice, when first
postoperative day review had been withdrawn. Pain may
be indeed an alarming sign for punctuate epitheliopathy
as well [13]. Worthy of note, the meaningful triad of
inflammation-related signs i.e., corneal edema, Tyndall
effect, conjunctival hyperemia seemed to follow the
same trend in both groups [10].
Overall, the most frequent postoperative complication
in our study was elevated intraocular pressure. This is in
agreement with the findings of previous investigations
[3,7,8]. Interestingly, Dinakaran et al. highlighted that
first postoperative day review is necessary, so as to check
intraocular pressure [7]. However, it has been shown
that the postoperative rise in intraocular pressure is
transient as its peak occurs between 3 and 6 hours post-
operatively [14]. Of note, intraocular pressure elevation
is more common in the subset of patients with coexist-
ing glaucoma and can be prevented by using prophylac-
tic topical intraocular pressure lowering agents [3,15,16].
Taken as whole, first postoperative day review may offer
little to the reduction of intraocular pressure.
The rationale for examining patients on the first post-
operative day pertains to detect treatable early complica-
tions. Furthermore, patients feel more reassured and canbe educated in postoperative care and drop installation
[3,8]. Nevertheless, severe complications, such as
endophthalmitis and retinal detachment, are rare and
not necessarily detected on the first postoperative day
[3,4,8], as our study also suggests. As a result, it seems
better to have a review on postoperative day 3 to 4 in-
stead of first postoperative day review. It is also import-
ant to ensure that all patients might easily have access to
eye care providers postoperatively at any time, so as to
be appropriately advised if they have any discomfort or
sight-threatening symptom.
A meaningful limitation of this study that should be
declared pertains to the design of the study. A blind
(masked) assessment at day 14 and 28 was not feasible,
as the team of surgeons performing the phacoemulsifica-
tion procedure were essentially the same as the evalu-
ation team. Nevertheless, it should be stressed that two
independent examiners evaluated the patients with 100%
agreement, a fact pointing to the rather negligible effect
mediated by the non-blind evaluation.
Conclusion
In conclusion, this study indicates that first postopera-
tive day review could be omitted in cases of uneventful
phacoemulsification cataract surgery, supplemented by
patients-initiated review in the interim.
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